Saved in:
Bibliographic Details
Main Authors: Whitney Querini‐Sanguillén, Jennifer Otero‐González, Melannie García‐Sánchez, Daniel Zúñiga‐Núñez, Germán Günther, Mario L. Miranda, Edgardo Castro‐Pérez, Carlos Ramos, Denis Fuentealba, José Robinson‐Duggon
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:https://onlinelibrary.wiley.com/doi/10.1111/php.14066
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867002819488251904
author Whitney Querini‐Sanguillén
Jennifer Otero‐González
Melannie García‐Sánchez
Daniel Zúñiga‐Núñez
Germán Günther
Mario L. Miranda
Edgardo Castro‐Pérez
Carlos Ramos
Denis Fuentealba
José Robinson‐Duggon
author_facet Whitney Querini‐Sanguillén
Jennifer Otero‐González
Melannie García‐Sánchez
Daniel Zúñiga‐Núñez
Germán Günther
Mario L. Miranda
Edgardo Castro‐Pérez
Carlos Ramos
Denis Fuentealba
José Robinson‐Duggon
Whitney Querini‐Sanguillén
Jennifer Otero‐González
Melannie García‐Sánchez
Daniel Zúñiga‐Núñez
Germán Günther
Mario L. Miranda
Edgardo Castro‐Pérez
Carlos Ramos
Denis Fuentealba
José Robinson‐Duggon
collection Wiley Open Access
contents Toluidine blue O demethylated photoproducts as type II photosensitizers Whitney Querini‐Sanguillén Jennifer Otero‐González Melannie García‐Sánchez Daniel Zúñiga‐Núñez Germán Günther Mario L. Miranda Edgardo Castro‐Pérez Carlos Ramos Denis Fuentealba José Robinson‐Duggon Photochemistry and Photobiology AbstractToluidine blue O (TBO) is a type I–type II photosensitizer that has shown good efficacy and selectivity in antimicrobial and anticancer photodynamic therapy applications. However, its complex photochemistry with multiple photoproducts hinders its application as a photosensitizer. We have previously described the mechanism for photooxidative demethylation of TBO which in acetonitrile yields two main products: demethylated‐TBO (d‐TBO) and double‐demethylated‐TBO (dd‐TBO). In the current work, we describe the photophysical properties of these two photoproducts. In acetonitrile and phosphate buffer, demethylation induces an hypsochromic shift in the absorption and fluorescence emission maxima. Fluorescence quantum yields increase slightly for the demethylated photoproducts, in agreement with the lengthening of the fluorescence lifetimes. Triplet excited states lifetimes in the presence of oxygen decreased slightly upon demethylation. However, the singlet oxygen quantum yield increased significantly reaching unity for the dd‐TBO photoproduct. These results are interpreted in terms of the competing pathways of TBO photochemistry. For TBO, demethylation is the main pathway for deactivation of the excited state, while for d‐TBO, demethylation and singlet oxygen generation are significant. For dd‐TBO, singlet oxygen generation is the main deactivation pathway. Overall, TBO demethylated photoproducts demonstrate good potential as candidates for photodynamic therapy applications. 10.1111/php.14066 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1111/php.14066
format Artículo Open Access
id wiley_oa_10_1111_php_14066
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Toluidine blue O demethylated photoproducts as type II photosensitizers
Whitney Querini‐Sanguillén
Jennifer Otero‐González
Melannie García‐Sánchez
Daniel Zúñiga‐Núñez
Germán Günther
Mario L. Miranda
Edgardo Castro‐Pérez
Carlos Ramos
Denis Fuentealba
José Robinson‐Duggon
Photochemistry and Photobiology
Toluidine blue O demethylated photoproducts as type II photosensitizers Whitney Querini‐Sanguillén Jennifer Otero‐González Melannie García‐Sánchez Daniel Zúñiga‐Núñez Germán Günther Mario L. Miranda Edgardo Castro‐Pérez Carlos Ramos Denis Fuentealba José Robinson‐Duggon Photochemistry and Photobiology AbstractToluidine blue O (TBO) is a type I–type II photosensitizer that has shown good efficacy and selectivity in antimicrobial and anticancer photodynamic therapy applications. However, its complex photochemistry with multiple photoproducts hinders its application as a photosensitizer. We have previously described the mechanism for photooxidative demethylation of TBO which in acetonitrile yields two main products: demethylated‐TBO (d‐TBO) and double‐demethylated‐TBO (dd‐TBO). In the current work, we describe the photophysical properties of these two photoproducts. In acetonitrile and phosphate buffer, demethylation induces an hypsochromic shift in the absorption and fluorescence emission maxima. Fluorescence quantum yields increase slightly for the demethylated photoproducts, in agreement with the lengthening of the fluorescence lifetimes. Triplet excited states lifetimes in the presence of oxygen decreased slightly upon demethylation. However, the singlet oxygen quantum yield increased significantly reaching unity for the dd‐TBO photoproduct. These results are interpreted in terms of the competing pathways of TBO photochemistry. For TBO, demethylation is the main pathway for deactivation of the excited state, while for d‐TBO, demethylation and singlet oxygen generation are significant. For dd‐TBO, singlet oxygen generation is the main deactivation pathway. Overall, TBO demethylated photoproducts demonstrate good potential as candidates for photodynamic therapy applications. 10.1111/php.14066 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Toluidine blue O demethylated photoproducts as type II photosensitizers
topic Photochemistry and Photobiology
url https://onlinelibrary.wiley.com/doi/10.1111/php.14066